Chemoinformaics analysis of Chrysanthenyl hexanoate
| Molecular Weight | 250.382 | nRot | 5 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 9 |
| Exact Molecular Weight | 250.193 | nRing | 3 |
| Solubility: LogS | -5.863 | nHRing | 0 |
| Solubility: LogP | 5.147 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 45.6606 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.417 |
| Synth | 4.294 |
| Natural Product Likeliness | 2.118 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.305 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.506 |
| MDCK | 0.0000191 |
| BBB | 0.627 |
| PPB | 0.965604 |
| VDSS | 1.278 |
| FU | 0.0376606 |
| CYP1A2-inh | 0.327 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.598 |
| CYP2c19-sub | 0.601 |
| CYP2c9-inh | 0.581 |
| CYP2c9-sub | 0.831 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.216 |
| CYP3a4-inh | 0.593 |
| CYP3a4-sub | 0.29 |
| CL | 13.009 |
| T12 | 0.06 |
| hERG | 0.016 |
| Ames | 0.005 |
| ROA | 0.483 |
| SkinSen | 0.261 |
| Carcinogencity | 0.05 |
| EI | 0.032 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.031 |
| Antiviral | Yes |
| Prediction | 0.824666 |